Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 41 Lymphoma 16 Urinary Bladder Neoplasms 7 Melanoma 6 Prostatic Neoplasms 3 Neoplasms 3 Leukemia 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Testicular Neoplasms 2 Testicular Germ Cell Tumor 2 Skin Neoplasms 2 Lymphoma, Large-Cell, Anaplastic 2 Central Nervous System Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Urothelial Carcinoma of the Bladder 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Teratoma 1 Survival Without Progression 1 Seminoma 1 Rhabdoid Tumor 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pathologic Complete Response 1 Oligodendroglioma 1 Neurofibromatosis 1 1

Interventions

Vinblastine 1 Methotrexate 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Survival Without Progression × Vinblastine × Clear all

NCT01285817 2023-03-13

SFCE METRO 01

Assistance Publique Hopitaux De Marseille

Phase 2 Completed

Survival Without Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡